Delivery Order SPE2DB24D1205-SPE2DB25FCUZE

Award Date 3/17/25
Potential Completion Date 4/7/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $32,467.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for IMBRUVICA 140 MG CAPSULE 90S, with an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 firm fixed price delivery order is for IMBRUVICA 140 MG CAPSULE 90S, with a period of performance through March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMBRUVICA 140 MG CAPSULE 120S. The $10,822.49 firm-fixed-price delivery order has a completion date of March 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 firm fixed-price delivery order is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules, a specialty medication used for various medical treatments. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $8,116.87, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of January 15, 2025. This award does not have a set-aside designation, indicating open...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order worth $8,116.87 to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the supply of IMBRUVICA 140 mg capsules. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,727.25, is a delivery order for the supply of IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,537.16 firm-fixed-price delivery order is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication, with a period of performance through November 13, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,233.74, is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCUZE
    Delivery Order

This federal contract award, valued at $8,116.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a specialty medication. This is a firm-fixed-price delivery order contract, with an ultimate completion date of April 7, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:42 AM